Capecitabine vs CYP2C9 Substrates (High risk)

Interacting Drugs
Capecitabine
vs
CYP2C9 Substrates (High risk)
Security Level
Moderate, Consider therapy modification
Mechanism
CYP2C9 Substrates (High risk): CYP2C9 Inhibitors (Strong) may decrease the metabolism of CYP2C9 Substrates (High risk).
Management
Consider therapy modification

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Capecitabine vs CYP2C9 Substrates (High risk)


Other Interactions of Capecitabine

We are Developing Our database, More results coming soon.

Other Interactions of CYP2C9 Substrates (High risk)

We are Developing Our database, More results coming soon.